doi: 10.1080/21548331.1982.11702368.
Beta-adrenergic blockade in clinical practice
- PMID: 6125468
- DOI: 10.1080/21548331.1982.11702368
Item in Clipboard
Beta-adrenergic blockade in clinical practice
Hosp Pract (Off Ed).
1982 Sep.
Abstract
Although all beta-blocking agents have similar pharmacologic effects, they have vastly different pharmacokinetic properties, which can influence the clinical usefulness of a given beta blocker in an individual patient. The efficacy of these drugs in a host of disorders-both cardiovascular and noncardiovascular-and their modes of action in these clinical contexts are examined and discussed.
Similar articles
-
Differential pharmacological properties of beta-adrenoceptor blocking drugs.J Cardiovasc Pharmacol. 1983;5 Suppl 1:S1-7. doi: 10.1097/00005344-198300051-00001. J Cardiovasc Pharmacol. 1983. PMID: 6188914 Review.
-
Basis for cardiovascular therapy with beta-blocking agents.Am J Cardiol. 1983 Nov 10;52(9):2D-9D. doi: 10.1016/0002-9149(83)90636-7. Am J Cardiol. 1983. PMID: 6139010 Review.
-
Beta-adrenergic blockade. An update.Cardiology. 1985;72(5-6):280-96. doi: 10.1159/000173885. Cardiology. 1985. PMID: 2866839 Review.
-
Beta-adrenoceptor blocking drugs in therapy.Q Med Rev. 1986 Jul;37(3):1-29. Q Med Rev. 1986. PMID: 2884692 No abstract available.
-
Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.Am J Med. 1984 Oct 5;77(4A):119-27. doi: 10.1016/s0002-9343(84)80047-9. Am J Med. 1984. PMID: 6148890 Review.